SynCore Biotechnology Co (ROCO:4192) Cyclically Adjusted Book per Share: NT$28.67 (As of Dec. 2025)


ROCO:4192 SynCore Biotechnology Co Ltd ROCO:4192
67 GF Score
Price NT$20.50
GF Value NT$47.93
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is SynCore Biotechnology Co Cyclically Adjusted Book per Share?

SynCore Biotechnology Co ROCO:4192 67 Cyclically Adjusted Book per Share is NT$28.67 as of Dec. 2025. GuruFocus rates ROCO:4192 with a GF Score™ of 67/100 and a GF Value™ of NT$47.93 (Possible Value Trap). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

SynCore Biotechnology Co's adjusted book value per share for the three months ended in Dec. 2025 was NT$6.985. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$28.67 for the trailing ten years ended in Dec. 2025.

During the past 12 months, SynCore Biotechnology Co's average Cyclically Adjusted Book Growth Rate was -17.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of SynCore Biotechnology Co was -10.40% per year. The lowest was -10.40% per year. And the median was -10.40% per year.

As of today (2026-07-12), SynCore Biotechnology Co's current stock price is NT$20.50. SynCore Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$28.67. SynCore Biotechnology Co's Cyclically Adjusted PB Ratio of today is 0.72.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SynCore Biotechnology Co was 2.63. The lowest was 0.68. And the median was 1.00.


SynCore Biotechnology Co  (ROCO:4192) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SynCore Biotechnology Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=20.50/28.67
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SynCore Biotechnology Co was 2.63. The lowest was 0.68. And the median was 1.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


SynCore Biotechnology Co Cyclically Adjusted Book per Share Related Terms


SynCore Biotechnology Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for SynCore Biotechnology Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SynCore Biotechnology Co Cyclically Adjusted Book per Share Chart

SynCore Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 39.85 37.62 34.74 28.67

SynCore Biotechnology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.74 33.16 31.68 30.38 28.67

ROCO:4192 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynCore Biotechnology Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Cyclically Adjusted PB Ratio falls into.


ROCO:4192
67GF Score
SynCore Biotechnology Co Ltd ROCO:4192
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SynCore Biotechnology Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SynCore Biotechnology Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=6.985/324.0540*324.0540
=6.985

Current CPI (Dec. 2025) = 324.0540.

SynCore Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 47.456 238.132 64.579
201606 42.245 241.018 56.799
201609 52.808 241.428 70.881
201612 50.966 241.432 68.407
201703 47.248 243.801 62.801
201706 44.080 244.955 58.314
201709 41.708 246.819 54.759
201712 38.005 246.524 49.957
201803 35.990 249.554 46.734
201806 31.090 251.989 39.981
201809 36.990 252.439 47.484
201812 31.235 251.233 40.289
201903 28.739 254.202 36.636
201906 23.043 256.143 29.152
201909 28.050 256.759 35.402
201912 23.161 256.974 29.207
202003 20.017 258.115 25.131
202006 26.760 257.797 33.638
202009 23.039 260.280 28.684
202012 19.381 260.474 24.112
202103 26.851 264.877 32.850
202106 24.036 271.696 28.668
202109 16.982 274.310 20.062
202112 14.182 278.802 16.484
202203 12.928 287.504 14.572
202206 11.598 296.311 12.684
202209 10.568 296.808 11.538
202212 7.973 296.797 8.705
202303 7.155 301.836 7.682
202306 6.343 305.109 6.737
202309 5.371 307.789 5.655
202312 10.156 306.746 10.729
202403 9.931 312.332 10.304
202406 9.308 314.175 9.601
202409 8.871 315.301 9.117
202412 8.380 315.605 8.604
202503 7.958 319.799 8.064
202506 7.564 322.561 7.599
202509 7.336 324.800 7.319
202512 6.985 324.054 6.985

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$28.67 mean?
SynCore Biotechnology Co (ROCO:4192) has a Cyclically Adjusted Book per Share of NT$28.67 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on SynCore Biotechnology Co and its competitors.
Is SynCore Biotechnology Co's Cyclically Adjusted Book per Share too high?
SynCore Biotechnology Co's current Cyclically Adjusted Book per Share is NT$28.67. Overall, SynCore Biotechnology Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SynCore Biotechnology Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
SynCore Biotechnology Co's Cyclically Adjusted Book per Share of NT$28.67 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on SynCore Biotechnology Co and its competitors. SynCore Biotechnology Co's current Cyclically Adjusted Book per Share is NT$28.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SynCore Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, SynCore Biotechnology Co (ROCO:4192) is currently considered Possible Value Trap. The stock's GF Value™ is NT$47.93, compared to a current price of NT$20.50 — trading 57.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$28.67. SynCore Biotechnology Co's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For SynCore Biotechnology Co (ROCO:4192), the current Cyclically Adjusted Book per Share is NT$28.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SynCore Biotechnology Co (ROCO:4192) Overvalued in 2026?

Based on GuruFocus' analysis, SynCore Biotechnology Co stock appears to be undervalued. The current stock price of NT$20.50 is trading 57.2% below its estimated GF Value™ of NT$47.93. GuruFocus considers SynCore Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:4192:

  • Cyclically Adjusted Book per Share: NT$28.67
  • GF Value™: NT$47.93 vs. price of NT$20.50 (57.2% below fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SynCore Biotechnology Co Business Description

Address No. 84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biotechnology company. The pipeline products of the company include SB01 and 02, SB03, SB04, SB05, and Others. It is engaged in new drug development and sales, healthy food development and sales, medicine inspection, biotechnology services, and intellectual property. It operates in a single industry, the new drug development. The company generates the majority of its revenue from medical products and healthy food.
67GF Score

Get the complete analysis for ROCO:4192

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.50
Price
NT$47.93
GF Value